|
Although blood transfusions can be life-saving, they are not without
risks. The most serious risks are transfusion reactions and infections.
Transfusion reactions
Blood product transfusions sometimes cause transfusion
reactions. There are several types of reactions and some are more
severe than others. Some reactions may happen as soon as the
transfusion is started, while some take several days or even longer to
develop.
Many precautions are taken before a transfusion is started to
keep reactions from happening. The blood type of the unit is checked
many times, and the unit is cross-matched to be sure that it matches
the blood type of the person who will receive it. After that, a nurse
and blood bank lab technician look together at the information about
the patient and the information on the unit of blood (or blood
component) before it is released. The information is double-checked
once more in the patient's presence before the transfusion is started.
Allergic
reaction: This is the most common type of reaction. It
occurs during the transfusion because of the body's reaction to plasma
proteins in the donated blood. Usually the only symptoms are hives and
itching, which can be treated with antihistamines such as
diphenhydramine (Benadryl). In rare cases these reactions can be more
serious.
Febrile reaction:
Febrile transfusion reactions mean that a person gets a sudden fever
during or within 24 hours of the transfusion. Headache, nausea, chills,
or a general feeling of discomfort may come with the fever.
Acetaminophen (Tylenol) may help these symptoms. These reactions are a
response by the body to white blood cells in the donated blood. They
are more common in people who have had transfusions before, and in
women who have had several pregnancies. Other types of reaction can
also cause fever, and further testing may be needed to be sure that the
reaction is only a febrile one.
Patients who have had febrile reactions or who are at risk for
them are usually given blood products that are leukoreduced. This
means that the white blood cells have been removed by filters or other
means.
Transfusion-related
acute lung injury (TRALI): This is a very serious
transfusion reaction, which happens in about 1 out of every 5,000
transfusions. It can happen with any type of transfusion, but those
that contain more plasma, such as FFP or platelets, seem more likely to
cause the problem. It often starts within 1 to 2 hours of the
transfusion, but can happen anytime up to 6 hours after a transfusion.
The main symptom a patient will feel is trouble breathing. Doctors now
believe that there are several factors involved in this illness, and
medicines don’t seem to help. Many of the patients who get TRALI have
had recent surgery, trauma, cancer treatment, transfusion, or have an
active infection. Most of the time TRALI goes away within 2 or 3 days
if the breathing and blood pressure are supported, but even with
support it can cause death in 5% to 10% of cases. It is more likely to
be fatal if the patient was already very ill before the transfusion.
Most often a patient will need oxygen, fluids, and sometimes support
with a breathing machine.
If a patient who has had TRALI needs blood, doctors will often
try to prevent future problems by "washing" the red cells in a dilute
salt water solution to remove most of the plasma while saving the red
blood cells.
Acute immune
hemolytic reaction: This is the most serious type of
transfusion reaction, but it is very rare. It happens when donor and
patient blood types do not match. The patient's antibodies attack the
transfused red blood cells, causing them to break open (hemolyze) and
release harmful substances into the bloodstream. Patients may have
chills, fever, chest and lower back pain, and nausea. The kidneys may
be severely damaged, and dialysis may be needed. A hemolytic reaction
can be cause death if the transfusion is not stopped as soon as the
reaction starts.
Delayed
hemolytic reaction: This type of reaction happens when the
body slowly attacks antigens (other than ABO antigens) on the
transfused blood cells. The blood cells break down days or weeks after
transfusion. There are usually no symptoms, but the transfused red
blood cells are destroyed and the patient's red blood cell count falls.
In rare cases the kidneys may be affected, requiring treatment.
People don't usually have these types of reactions unless they
have had several transfusions in the past. People who have this type of
reaction need special blood testing before any more blood can be
transfused. Units of blood that do not have the antigen that the body
is attacking must be used.
Graft-versus-host
disease (GVHD): GVHD occurs when white blood cells in
transfused blood attack the tissues of a transfusion recipient who has
a severely weakened immune system. It is more likely to happen if the
person getting the blood is a relative or has a similar tissue type to
the donor. The recipient's immune system doesn't recognize the white
blood cells in the transfused blood as foreign. This allows them to
survive and attack the recipient's body tissues. Within a month of the
transfusion, the patient may have fever, liver problems, rash, and
diarrhea. To prevent white blood cells from causing GVHD, donated blood
can be treated with radiation before transfusion. Radiation stops white
blood cells from working but does not affect red blood cells.
Infections
Blood transfusions can transmit infections caused by bacteria,
viruses, and parasites. The chance of an infection being transmitted is
very rare, but the exact risk for each type of infection varies.
Testing units of blood for germs that can cause infections has made the
blood supply extremely safe, but no test is 100% accurate.
Bacterial
contamination: Rarely, blood gets contaminated with tiny
amounts of skin bacteria during donation. Platelets are the most likely
blood component to have this problem. Because platelets must be stored
at room temperature, these bacteria can grow rapidly. This affects
about 1 in 1000 to 3000 units of platelets. Patients receiving these
platelets may develop serious illness within minutes or hours after the
transfusion is started. In 2004, blood banks started testing platelets
before they are given and throwing out affected units.
Hepatitis B and
C: Viruses that attack the liver cause these forms of
hepatitis. Hepatitis is the most common disease transmitted by blood
transfusions. According to the American Red Cross, about 1 blood
transfusion in 205,000 transmits a hepatitis B infection, and 1 blood
transfusion in about 2 million transmits hepatitis C. In most cases
there are no symptoms, but hepatitis can sometimes lead to liver
failure and other problems.
Several steps are routinely taken to reduce the risk of
hepatitis from blood transfusion. People who are getting ready to
donate blood are asked questions about hepatitis risk factors and
symptoms of hepatitis. Donated blood is also tested to find hepatitis B
virus, hepatitis C virus, and liver problems that might point to other
types of hepatitis.
Human
immunodeficiency virus (HIV): HIV causes acquired immune
deficiency syndrome (AIDS). Testing each unit of donated blood for HIV
began in 1985, and tests for HIV are now used on all donated blood.
With improved testing for HIV, the number of transfusion-related AIDS
cases continues to drop. The risk of HIV transmission from a
transfusion is about now about one in 2,135,000. In addition to
testing, the risk is reduced by asking donors questions about HIV risk
factors and symptoms.
Other infections
tested for: In addition to the tests noted above, all
blood for transfusion is tested for syphilis, as well as HTLV-I and
HTLV-II, viruses linked to human T-cell leukemia/lymphoma. Since 2003,
donated blood has been tested for the West Nile virus too.
Other possible
infections: Diseases caused by certain bacteria, viruses,
and parasites, such as babesiosis, Chagas disease, malaria, Lyme
disease, and others can also be spread by blood product transfusions.
But because potential donors are screened with questions about their
health status and travel, such cases are very rare.
Revised: 03/08/2008
|